Simon Egyin
YOU?
Author Swipe
View article: Safety and Efficacy of Dupilumab, Omalizumab, and Mepolizumab in Moderate-to-Severe Asthma: A Systematic Review
Safety and Efficacy of Dupilumab, Omalizumab, and Mepolizumab in Moderate-to-Severe Asthma: A Systematic Review Open
Biologic therapies such as dupilumab, omalizumab, and mepolizumab have significantly revolutionized the treatment options for moderate-to-severe asthma, particularly in patients with type 2 inflammation. This systematic review aims to comp…